Autres langues Morepen Laboratories Limited

Actions

MOREPENLAB

INE083A01026

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:27:29 06/08/2026			Varia. 5j.	Varia. 1 janv.
79,48 ^INR	+3,26%		+37,46%	+93,52%

05/08	Morepen Laboratories Limited annonce le versement d'un dividende annuel, payable le 26 octobre 2026	CI
04/08	Morepen Laboratories Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI

Autres langues

05/08	Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026
04/08	Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
04/08	Morepen Laboratories : Q1'FY27 Investor Presentations
01/07	Morepen Laboratories Limited Accelerates Manufacturing Expansion, Plans 1,000 KL Reactor Capacity
01/07	Morepen Scales Up CDMO Program, Expects INR 2.25 Billion Supplies in Second Quarter of 2027
26/05	Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
26/05	Morepen Laboratories : Audited Financial results for the quarter and financial year ended March 31, 2026 Unaudited financial results for the quarter and nine months ended December 31, 2025 Unaudited Financial results for the quarter and half year ended September 30, 2025 Unaudited Financial results for the quarter ended June 30, 2025
26/05	Morepen Laboratories Limited Recommends Final Dividend for the Year Ended 31 March, 2026
26/05	Morepen Laboratories March-quarter consol net profit 157 million rupees
20/05	Anubhav Suri agreed to acquire an additional 9% stake in Morepen Medipath Limited from Morepen Laboratories Limited.
23/04	Morepen Laboratories Limited Approves Unsecured Term Loan Facility of INR 300 Million from Shinhan Bank
17/04	Morepen Laboratories : Secures Fourth Consecutive USFDA Inspection with Zero Observations (NIL 483)
17/04	Morepen Laboratories says USFDA clears Masulkhana API facility with nil Form 483 observations
17/04	Morepen Laboratories Limited Receives USFDA Clearance for Masulkhana Facility Inspection with Zero Observations
24/02	IT rout drags Indian markets; sector on track for worst month in 23 years on AI fears
23/02	Morepen Laboratories gets order worth 8.25 bln rupees
23/02	Morepen Laboratories Secures INR8.25 Billion CDMO Mandate; Shares Jump 13%
23/02	Morepen Laboratories : Bags ₹825 Crore Global Deal; Expands Into High-Growth CDMO Segment.
23/02	Morepen Laboratories : Bags ₹825 Crore Global Deal
23/02	Morepen Laboratories secures 8.25 billion rupees CDMO deal
23/02	Morepen Laboratories Limited Secures Multi-Year Contract Development and Manufacturing Organization
12/02	Morepen Laboratories Limited Executes Loan Agreement and Other Related Documents with Woori Bank
10/02	Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
10/02	Morepen Laboratories : Q3'FY26 Presentation
10/02	Morepen Laboratories Dec-quarter Consol Net Profit 275.1 Million Rupees